GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo

por Lim, Okjae, Lee, Yuna, Chung, Hyejin, Her, Jung Hyun, Kang, Sang Mi, Jung, Mi-young, Min, Bokyung, Shin, Hyejin, Kim, Tae Min, Heo, Dae Seog, Hwang, Yu Kyeong, Shin, Eui-Cheol
Publicado 2013

CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation

por Gao, Jing, Wang, Zhengyi, Jiang, Wenqing, Zhang, Yanni, Meng, Zhen, Niu, Yanling, Sheng, Zhen, Chen, Chan, Liu, Xuejun, Chen, Xi, Liu, Chanjuan, Jia, Keren, Zhang, Cheng, Liao, Haiyan, Jung, Jaeho, Sung, Eunsil, Chung, Hyejin, Zhang, Jingwu Z., Zhu, Andrew X., Shen, Lin
Publicado 2023

B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8(+) tumor-infiltrating lymphocytes

por You, Gihoon, Lee, Yangsoon, Kang, Yeon-Woo, Park, Han Wook, Park, Kyeongsu, Kim, Hyekang, Kim, Young-Min, Kim, Sora, Kim, Ji-Hae, Moon, Dain, Chung, Hyejin, Son, Wonjun, Jung, Ui-jung, Park, Eunyoung, Lee, Shinai, Son, Yong-Gyu, Eom, Jaehyun, Won, Jonghwa, Park, Yunji, Jung, Jaeho, Lee, Seung-Woo
Publicado 2021